Vaccines
Until now, it was not clear how SARS-CoV-2-specific T cell responses relate to antibody responses or to the clinical course of COVID-19 in humans
| 2 min read
Labs and equipment used for monitoring of plant and animal diseases could easily be adapted for diagnostic testing and tracing in a human pandemic or epidemic
| 3 min read
Multi-site trial to test candidate developed by Moderna and NIH
| 4 min read
The findings from researchers at the Universities of Bath and Edinburgh could help in the design of vaccines against the virus
| 3 min read
A single dose induced antibodies in both young and old animal models. The vaccine's design has advantages of safety, cost, scalability, and storage
| 3 min read
Faced with limitations of egg-based vaccine production, researchers have turned to other approaches
| 4 min read
Learn how asymmetrical flow field-flow fractionation (AF4) techniques can help virus, vaccine, and antibody researchers
| 1 min read
Breakthroughs in developing vaccines, protective immune monitoring, and measuring toxicity with functional proteomics
| 1 min read
The protein structure facilitates viral entry into host cells making it a key target for vaccine and antiviral drug development, according to the researchers
| 2 min read
Salk and Yale study of influenza could inform vaccines for COVID-19 and other lung diseases
| 3 min read
